NEW YORK (GenomeWeb) – Invitae has priced its offering of 11,111,111 shares of its common stock at a price of $4.50 per share.

The genetic testing firm had said earlier this week that it expected to offer 7,122,507 shares. But its stock price has tumbled since announcing the planned offering, from a close of $7.00 on Monday to a close of $4.84 yesterday on the New York Stock Exchange.

Invitae said that it expects gross proceeds from the offering of around $50.0 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.